Researchers have shared an updated analysis of the SMART-CHOICE study, focusing on major adverse cardiac and cerebrovascular events—as well as bleeding events—among PCI patients after three years. 

New research in JACC: Cardiovascular Interventions suggests improved collaborations between cardiologists and neurologists could help TAVR patients live longer after a periprocedural stroke. 

Pulmonary artery denervation may offer a new therapy option for this difficult-to-treat population.

The UNIVERSAL Trial, one of the largest multicenter randomized trials comparing ultrasound with fluoroscopic guidance vs. fluoroscopic guidance alone, found there was no reduction in major vascular access complications. 

The company plans to integrate the newly acquired microcatheters into its existing robotics platforms. 

Progestin-only products may be a "safer alternative" for this patient population, according to a new analysis.